Discussion with Dr Carmen Oakley: Management of Glaucoma in patients with cataracts – the role of MIGS
Date: 12/06/2024 (ACST)
Venue: Level 1, 215 Greenhill Road, Eastwood, SA, 5063
Provider: Adelaide Eye & Laser Centre
Contact: Vanessa Potts, [E] Vanessa.Potts@aelc.com.au, [P] 0882747015
Activity Outline
The discussion will include interactive discussion of a number of patients cases.
This discussion will extend to include the role of MIGS in managing glaucoma and cataracts extends beyond its immediate effects. Studies suggest that MIGS procedures have a favorable safety profile, making them suitable for patients with mild to moderate glaucoma. This offers an opportunity for early intervention, potentially slowing disease progression and preserving vision in the long term.
The session will discuss common MIGS devices often implanted during cataract surgery, streamlining the patient's treatment process and how by combining cataract removal with a MIGS procedure, patients benefit from improved visual acuity, reduced dependence on glaucoma medications, and better IOP control.
MIGS procedures fill a crucial gap in glaucoma management for these patients. Unlike conventional surgeries, MIGS techniques are designed to be less invasive, with a favorable safety profile and rapid recovery times. MIGS procedures target different areas of the eye's natural drainage system to enhance aqueous outflow, reducing intraocular pressure (IOP) and managing glaucoma progression.
Glaucoma, a leading cause of irreversible blindness, often coexists with cataracts, a clouding of the eye's natural lens. This dual pathology requires a careful approach to preserve vision and quality of life. Traditional treatment options for glaucoma, such as topical medications and invasive surgeries like trabeculectomy, may pose risks in cataract patients, including exacerbating cataract formation or inducing postoperative complications.
Management of glaucoma in patients with cataracts presents a unique challenge due to the need to address both conditions effectively while minimising potential complications. Minimally Invasive Glaucoma Surgery (MIGS) has emerged as a promising option in this scenario, offering a balance of efficacy and safety. This interactive discussion will explore this area of ophthalmology and its risks and how to identify relevant patients.
Learning Objectives
- Identify glaucoma patients who may benefit from surgical management of glaucoma
- Identify patients appropriate for minimally invasive glaucoma surgery
- Understand risks and benefits associated with combining cataract surgery with minimally invasive glaucoma surgery
Max CPD hours awarded: 2
Session Information
| Name |
|---|
| Minimally invasive glaucoma surgery – what is it and when is it indicated? |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 2 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 2 |